Clinical Trials in Salt Lake City

Showing 5981-6000 of 16,694 trials

Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool

NCT03936985

The goal of the study is to validate a Prescription Drug Monitoring Program-based opioid risk metric to discriminate between low, moderate, and high-risk opioid use disorder. The World Health Organization Alcohol, Smoking, and Substance Involvement Screening Test (WHO ASSIST) will be used as the gold standard instrument that defines patient risk levels. No intervention or hypothesis will be tested.

Opioid AbusePrescription Drug Abuse (Not Dependent)

University of Utah1,464 participantsStarted Nov 2019

Cincinnati, Ohio, United States • Salt Lake City, Utah, United States

COMPLETEDNA< 1 mile

Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.

NCT04054505

The purpose of this study is to correlate the findings of an early study with current data.

Vitamin Deficiency

Optimal Health Research275 participantsStarted Jan 2019

Salt Lake City, Utah, United States

COMPLETEDPhase 3< 1 mile

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501666

The primary objective was to assess the efficacy of nemolizumab (CD14152) compared to placebo in participants greater than or equal to (\>=) 18 years of age with prurigo nodularis (PN) after a 16 week treatment period.

Prurigo Nodularis

Galderma R&D286 participantsStarted Sep 2020

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Los Angeles, California, United States +97 more locations

Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool

Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Find Trials by Condition in Salt Lake City

Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma

Feasibility Study on LITT for Medical Refractory Epilepsy

A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease

Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Impact of Microvascular Inflammation on Kidney Allograft Outcome

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

C-myc Biomarker Study for Diabetic Foot Ulcers

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia